Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Joshua Hare
Allina Health System, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vestion, Inc.
Other : Equity Interest: Value of the financial. Dr. Hare has an approximately (b)(4) equity in Vestion. Vestion is a start-up company whose value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Dr. Hare has a compound relationship with Vestion and the study uses his intellectual property in his research.
MN Regional Cardiovascular Cell Therapy Clinical Res. Network: From AMI to PAD
Despite all the therapeutic advances made to date, cardiovascular disease remains to be a major public health concern in the United States. Further understanding and translation of cell therapy into effective therapeutic modalities for cardiovascular disease may provide significant improvements to patients without options through the world. The MNCCTRN, with its clinical trial and cardiovascular cell therapy experience and infrastructure, will continue to make key contributions from basic science to multicenter clinical trials.
Filed on June 26, 2019.
Tell us what you know about Joshua Hare's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Joshua Hare”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Biscayne Pharmaceuticals | Value cannot be readily determined |
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Longeveron | $250,000 - $299,999 |
Joshua Hare | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Vestion, Inc. | $5,000 - $9,999 |
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Biscayne Pharmaceuticals | Value cannot be readily determined |
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Vestion, Inc | Value cannot be readily determined |
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Biscayne Pharmaceuticals | Value cannot be readily determined |
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Longeveron | Value cannot be readily determined |
Joshua Hare | University of Miami School of Medicine | Conflict of Interest | Longeveron, LLC | Value cannot be readily determined |
Joshua Hare | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Vestion, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.